In a brief communication, Brun et al56 describe the effect of polymorphisms in genes encoding the TLR4 and CD14 LPS receptors on 28 patients with NAFLD, including 21 with NASH, who were compared with 52 healthy controls. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.